Recursion Pharmaceuticals
RXRX
#4206
Rank
$1.97 B
Marketcap
$4.92
Share price
-6.90%
Change (1 day)
-43.84%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : $0.41 Billion USD

According to Recursion Pharmaceuticals's latest financial reports the company's total liabilities are $0.41 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Recursion Pharmaceuticals - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.41 B117.5%
2023-12-31$0.19 B-11.7%
2022-12-31$0.21 B219.67%
2021-12-31$67.4 M-86.65%
2020-12-31$0.50 B123.7%
2019-12-31$0.22 B